Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)

Market Cap	6.27B -12.7%
Revenue (ttm)	2.02B -7.1%
Net Income	463.31M -12.5%
EPS	1.97 -12.8%
Shares Out	234.33M
PE Ratio	13.57
Forward PE	10.45
Dividend	2.50 (9.37%)
Ex-Dividend Date	n/a

Volume	1,128,898
Open	27.08
Previous Close	26.68
Day's Range	26.50 - 27.08
52-Week Range	26.51 - 36.70
Beta	-0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 7, 2026

About Shandong Wit Dyne Health

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration salt powder, montmorillonite powder, azithromycin granules, rifaximin dry suspension, and succinate capsules. In addition, it offers information product...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 1,719
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000915

Financial Performance

In 2025, Shandong Wit Dyne Health's revenue was 2.23 billion, an increase of 4.40% compared to the previous year's 2.13 billion. Earnings were 535.08 million, an increase of 3.78%.